Cytogenetic characteristics predict outcome of patients with poor risk MDS and secondary AML (sAML) treated with intensive chemotherapy and stem cell transplantation in a joint study (CRIANT) of the EORTC, EBMT, SAKK, HOVON and GIMEMA Leukaemia Groups
2002; Springer Nature; Volume: 29; Linguagem: Inglês
ISSN
1476-5365
AutoresT de Witte, Anne Hagemeijer‐Hausman, Stefan Suciu, Michel Delforge, M Jotterand-Bellomo, Isabelle Tigaud, A Belhabri, Carlo Aul, M Avaido, Dominik Selleslag, H Schouten, A. Ferrant, Sergio Amadori, Petra Muus, Özlem Anak, F Beeldens, Jean Jansen, Eva Hellström‐Lindberg, Aloïs Gratwohl, R Willemze,
Tópico(s)Acute Myeloid Leukemia Research
Referência(s)